Chemotherapy-Induced Toxicities: An Imaging Primer[Formula: see text].

Patil, Nikhil S; Larocque, Natasha; van der Pol, Christian B; Torres, Carlos; Raptis, Demetrios A; Patlas, Michael N

Patil, Nikhil S; Larocque, Natasha; van der Pol, Christian B; Torres, Carlos; Raptis, Demetrios A; Patlas, Michael N.

Patil NS; Michael DeGroote School of Medicine, 62703McMaster University, Hamilton, ON, Canada.
Larocque N; Department of Radiology, 3710McMaster University, Hamilton, ON, Canada.
van der Pol CB; Department of Diagnostic Imaging, Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, Canada.
Torres C; Department of Radiology, Radiation Oncology and Medical Physics, 6363University of Ottawa, Ottawa, ON, Canada.
Raptis DA; Mallinckrodt Institute of Radiology, Washington University School of Medicine, USA.
Patlas MN; Department of Radiology, 3710McMaster University, Hamilton, ON, Canada.

Can Assoc Radiol J ; : 8465371221120263, 2022 Aug 13.

Article in English | MEDLINE | ID: covidwho-2275872

ABSTRACT

ABSTRACT

The Coronavirus Disease of 2019 (COVID-19) pandemic has caused significant delays in the delivery of cancer treatments in Canada. As cancer treatment and imaging volumes return to normal, radiologists will encounter more cases of chemotherapy-induced toxicities. These toxicities have varied appearances on imaging, and can affect multiple organ systems. The purpose of this review is to offer a unified resource for general radiologists regarding the imaging appearances of chemotherapy-induced toxicities.

Keywords

cancer; chemotherapy; chemotoxicity; immune checkpoint inhibitor

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Can Assoc Radiol J Journal subject: Radiology Year: 2022 Document Type: Article Affiliation country: 08465371221120263

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google